» Articles » PMID: 27679477

COEXPEDIA: Exploring Biomedical Hypotheses Via Co-expressions Associated with Medical Subject Headings (MeSH)

Overview
Specialty Biochemistry
Date 2016 Sep 29
PMID 27679477
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The use of high-throughput array and sequencing technologies has produced unprecedented amounts of gene expression data in central public depositories, including the Gene Expression Omnibus (GEO). The immense amount of expression data in GEO provides both vast research opportunities and data analysis challenges. Co-expression analysis of high-dimensional expression data has proven effective for the study of gene functions, and several co-expression databases have been developed. Here, we present a new co-expression database, COEXPEDIA (www.coexpedia.org), which is distinctive from other co-expression databases in three aspects: (i) it contains only co-functional co-expressions that passed a rigorous statistical assessment for functional association, (ii) the co-expressions were inferred from individual studies, each of which was designed to investigate gene functions with respect to a particular biomedical context such as a disease and (iii) the co-expressions are associated with medical subject headings (MeSH) that provide biomedical information for anatomical, disease, and chemical relevance. COEXPEDIA currently contains approximately eight million co-expressions inferred from 384 and 248 GEO series for humans and mice, respectively. We describe how these MeSH-associated co-expressions enable the identification of diseases and drugs previously unknown to be related to a gene or a gene group of interest.

Citing Articles

Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress.

Song H, Guo Z, Xie K, Liu X, Yang X, Shen R Cell Prolif. 2024; 58(2):e13759.

PMID: 39477811 PMC: 11839194. DOI: 10.1111/cpr.13759.


High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma.

Du N, Yi L, Wang J, Lei Y, Bo X, Guo F Sci Rep. 2024; 14(1):17246.

PMID: 39060453 PMC: 11282058. DOI: 10.1038/s41598-024-68348-0.


PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.

Liu Z, Han S, Luo Y, Zhao Z, Ni L, Chai L Cancer Manag Res. 2024; 16:199-214.

PMID: 38525370 PMC: 10961073. DOI: 10.2147/CMAR.S443490.


Identification of TACSTD2 as novel therapeutic targets for cisplatin-induced acute kidney injury by multi-omics data integration.

Deng Z, Dong Z, Wang Y, Dai Y, Liu J, Deng F Hum Genet. 2024; 143(9-10):1061-1080.

PMID: 38369676 DOI: 10.1007/s00439-024-02641-w.


Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis.

Liu Y, Xu Y, Shuai Z Sci Rep. 2023; 13(1):22862.

PMID: 38129425 PMC: 10739902. DOI: 10.1038/s41598-023-48950-4.


References
1.
Pei H, Li L, Fridley B, Jenkins G, Kalari K, Lingle W . FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell. 2009; 16(3):259-66. PMC: 2755578. DOI: 10.1016/j.ccr.2009.07.016. View

2.
Kami D, Shiojima I, Makino H, Matsumoto K, Takahashi Y, Ishii R . Gremlin enhances the determined path to cardiomyogenesis. PLoS One. 2008; 3(6):e2407. PMC: 2398777. DOI: 10.1371/journal.pone.0002407. View

3.
Miyake T, Nakayama T, Naoi Y, Yamamoto N, Otani Y, Kim S . GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci. 2012; 103(5):913-20. PMC: 7659189. DOI: 10.1111/j.1349-7006.2012.02231.x. View

4.
Shukla P, Singh K, Quan A, Al-Omran M, Teoh H, Lovren F . BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun. 2011; 2:593. PMC: 3247816. DOI: 10.1038/ncomms1601. View

5.
Kolesnikov N, Hastings E, Keays M, Melnichuk O, Tang Y, Williams E . ArrayExpress update--simplifying data submissions. Nucleic Acids Res. 2014; 43(Database issue):D1113-6. PMC: 4383899. DOI: 10.1093/nar/gku1057. View